RNA, 7SL, cytoplasmic 628, pseudogene (RN7SL628P)

RN7SL628P refers to RNA, 7SL, cytoplasmic 628, pseudogene, a member of a family of processed pseudogenes derived from the 7SL RNA, which itself is a non-coding RNA component of the signal recognition particle (SRP) complex[1][3][5]. Unlike its functional parental gene, which is involved in protein targeting to the endoplasmic reticulum, RN7SL628P does not produce a functional product owing to mutations and lack of regulatory sequences, making it a pseudogene[1][2][4]. While some pseudogenes have regulatory roles at DNA or RNA levels (e.g., as decoys for microRNAs or regulators of gene expression)[2], there is no evidence that RN7SL628P acts directly as a therapeutic target, encodes a receptor, enzyme, or other druggable protein[1][2]. Additionally, there is no information indicating drug interactions, use as a biomarker, or any disease association specific to RN7SL628P. As such, this gene should not be considered a canonical therapeutic target, and its inclusion as a drug or receptor target would be incorrect. The parent molecule, 7SL RNA, is involved in the SRP complex responsible for halting translation and targeting proteins to membranes, but RN7SL628P is a non-functional, non-coding pseudogene copy of this RNA[3][5].

Other names

RN7SL628PRNA, 7SL, cytoplasmic 628, pseudogene